RNA drug from Regeneron, Alnylam succeeds in rare autoimmune disease trial
Cemdisiran helped control symptoms of generalized myasthenia gravis, but combination treatment with a Regeneron antibody didn't appear as effective.
Previous Post
Kidney Stone Warning Signs That Demand Immediate Attention
Next Post
Medicare Advantage Enrollees Account for 25% of all Inpatient Hospital Days
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago